Profound Medical PROF EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Profound Medical’s reported figures.
Based on trailing twelve months.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's EBITDA margin?
- Profound Medical (PROF) reported EBITDA margin of -199.9% in Q1 2026.
- How has Profound Medical's EBITDA margin changed year-over-year?
- Profound Medical's EBITDA margin increased by 33.2% year-over-year, from -299.3% to -199.9%.
- What is the long-term trend for Profound Medical's EBITDA margin?
- Over 2 years (2023 to 2025), Profound Medical's EBITDA margin has grown at a -19.0% compound annual growth rate (CAGR), from -385.1% to -252.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.